Financial statements Transmed Kielce
Balance sheet data of TRANSMED KIELCE
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 123 110,86 | 119 209,99 | 71 796,73 | 77 514,69 | 265 182,73 | 1 000 628,62 |
| A. Fixed assets | 84 239,67 | 62 731,67 | 41 223,67 | 0,00 | 55 100,00 | 244 945,53 |
| B. Current assets | 38 871,19 | 56 478,32 | 30 573,06 | 77 514,69 | 210 082,73 | 755 683,09 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 123 110,86 | 119 209,99 | 71 796,73 | 77 514,69 | 265 182,73 | 1 000 628,62 |
| A. Equity | -19 962,05 | -41 501,66 | -77 679,27 | -71 943,91 | -354 055,26 | 92 028,21 |
| B. Liabilities and provisions for liabilities | 143 072,91 | 160 711,65 | 149 476,00 | 149 458,60 | 619 237,99 | 908 600,41 |
| I. Long-term liabilities | - | - | - | - | - | 0,00 |
| II. Short-term liabilities | - | - | - | - | - | 908 600,41 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.